To include your compound in the COVID-19 Resource Center, submit it here.

Korea’s Orum stays local with $30M round to build out cell-penetrating platform

To expand its cell-penetrating antibody platform and build out its R&D labs in Boston and South Korea, Orum

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE